The Procter & Gamble Company (NYSE:PG) Shares Sold by Sendero Wealth Management LLC

Sendero Wealth Management LLC decreased its position in shares of The Procter & Gamble Company (NYSE:PG) by 7.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,385 shares of the company’s stock after selling 1,318 shares during the period. Sendero Wealth Management LLC’s holdings in Procter & Gamble were worth $2,665,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the second quarter valued at $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth about $29,000. Transcendent Capital Group LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at about $31,000. Ruedi Wealth Management Inc. grew its position in shares of Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. Finally, POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble during the second quarter worth approximately $34,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

NYSE:PG traded down $0.70 during mid-day trading on Thursday, reaching $168.57. The stock had a trading volume of 1,792,494 shares, compared to its average volume of 6,658,988. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The business has a 50 day simple moving average of $171.39 and a 200 day simple moving average of $166.65. The Procter & Gamble Company has a twelve month low of $141.66 and a twelve month high of $177.94. The firm has a market capitalization of $397.85 billion, a price-to-earnings ratio of 27.54, a PEG ratio of 3.73 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same period in the previous year, the business earned $1.37 earnings per share. The company’s revenue for the quarter was down .1% compared to the same quarter last year. On average, analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.39%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on PG shares. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. TD Cowen assumed coverage on Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target for the company. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Citigroup upped their target price on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Ten equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $175.05.

Insider Transactions at Procter & Gamble

In other news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock valued at $65,140,718 in the last quarter. 0.17% of the stock is currently owned by corporate insiders.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.